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We report a case of clear cell carcinoma occurring in the prostate with Zinner syndrome in a 64-year-old
man. Based on the immunohistochemical ﬁndings, it was concluded that this tumor represented primary
renal-type clear cell carcinoma arising in the prostate. After receiving radical cystoprostatectomy, he was
treated with tyrosine kinase inhibitor (TKI) therapy for local recurrence in accordance with the protocol
of renal cell carcinoma (RCC) treatment, because microarray cluster analysis using a resected sample
demonstrated that the present case belonged to the cluster group of RCC.
 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Clear cell carcinoma (CCC) of the prostate is a very rare condi-
tion, and information reported in the literature is limited.1e4 Zinner
syndrome is characterized by the triad of ipsilateral renal agenesis,
seminal vesicle cyst, and ejaculatory duct obstruction.5 Herein, we
report a case of a 64-year-old man with Zinner syndrome who
developed renal-type CCC of the prostate. Immunohistochemical
and biologic features of renal-type CCC of the prostate are
discussed.Case presentation
A 64-year-old man presented with gross hematuria several days
in duration. The patient had been diagnosed with Zinner syndrome,
presenting with left renal agenesis (Fig. 1A), seminal vesicle cyst
(Fig. 1B) and ejaculatory duct obstruction (Fig. 1C), at the age of 45.
Digital rectal examination detected a hard, enlarged and non-
mobile prostate compressing the rectal wall. Laboratory examina-
tion revealed no abnormalities. The levels of PSA (0.19 ng/ml) were
within normal ranges. Urine analysis showed hematopyuria. Ul-
trasonography showed a heteroechoic prostate mass adjacent tokushima Medical University
295, Japan. Tel.: þ81 24 547
Inc. This is an open access article uthe seminal vesicle cyst. Computed tomography and magnetic
resonance imaging revealed a huge mass, measuring
54  58  67 mm, which occupied the pelvic cavity (Fig. 1D and E).
There was no evidence of metastatsis in any organ.
Ultrasound-assisted transperineal needle biopsy was conducted
to enable a pathological diagnosis. Histopathological examination
revealed CK7-positive and CK20- and PSA-negative non-ciliated
cuboidal cells, with the cytoplasm ranging from clear to eosino-
philic, suggestive of CCC (Fig. 2AeC). The patient underwent a
radical cystoprostatectomy with ileal conduit and bilateral lymph
node dissection. The tumor have grown expansively and adhered to
the urinary bladder, but did not invade the rectum.Macroscopically,
the resected specimen had an encapsulated mass with focal hem-
orrhages and necrosis. Microscopic ﬁndings exhibited morpholog-
ical and immunohisotchemical characteristics similar to those of
CCC of the kidney (Fig. 2D and E). Normal prostatic tissue was
almost replaced by CCC, but the coexistence of CCC and normal
prostate-like tissue without a deﬁned border between them was
identiﬁed in only a very small region (Fig. 2E). The results of an
immunohistochemical study using the resected sample were the
same as those of the biopsy sample. Based on these ﬁndings, it was
concluded that this tumor represented primary renal-type CCC
arising in the prostate.
Local recurrence in the pelvis was apparent 24 months after
surgery. In order to decide on a course of treatment, we performed
microarray cluster analysis using the sample of the present case,
and compared the gene expression proﬁling with prostate adeno-
carcinoma (prostate cancer: PCa), urothelial cell carcinoma (UCC)nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Abdominal and pelvic CT and vasography, which were performed 19 years before diagnosis of the pelvic mass, shows left renal agenesis (A), seminal vesicle cyst (B),
and ejaculatory duct obstruction (C), respectively. T2-weighted magnetic resonance image shows a large pelvic mass adjacent to the bladder (D), and seminal vesicle cyst (E).
Arrowheads: seminal vesicle cyst; small arrow: vas deferens; large arrows: large pelvic mass.
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for them in our department (Fig. 3). This microarray study was
approved by the ethics committee of our institution. Hierarchical
cluster analysis demonstrated separation of the cases into almost
three distinct groups, PCa, UCC and RCC, with large linkage dis-
tances apparent when clustering was performed with the gene
expression proﬁling. In the dendrogram, the present case belonged
to the cluster group of RCC, demonstrating that the present case had
a similar gene expression pattern to that of RCC. Therefore, he was
treated with TKI therapy (sunitinib malate 25 mg/day) in accor-
dance with the protocol of RCC treatment. However, the patient
succumbed to the disease 29 months after surgery due to multi-
organ system failure.
Discussion
Renal-type CCC of the prostate is extremely rare, but has been
reported in recent years.1e4 It is important to distinguish it from
other CCCs of the male urinary tract, including metastatic RCC, a
variant of PCa, UCC and adenocarcinoma of the urinary bladder, and
mullerian CCC.1 In the present case, the differential diagnosis was
suggestive of them. Themost possible considerationwas metastatic
RCC to the prostate, although there are very few existing reports of
RCC presenting with metastasis to the prostate at initial diagnosis.1
The clear cell lesion identiﬁed in the present case demonstrated an
immunohistochemical proﬁle almost identical to that of RCC, with
positive expression of CK7 and negative results of CK20 and PSA.However, there was no clinical or radiological evidence of renal
tumor in this patient. Although PCa corresponding to Gleason’s
grade 4 may have a clear cell or hypernephroid pattern, it should
stain positively for PSA. Urothelial carcinoma may have a clear cell
pattern, but it should stain positively for CK20. The remaining dif-
ferential diagnostic considerationwasmullerian CCC, which has the
presence of immunoactivity for CK7 and CK20. In the present case,
however, immunoactivity of CK20 was absent, and the coexistence
of CCC and normal prostate-like tissue without a deﬁned border
between themwas identiﬁed. Finally, the tumor in the present case
was considered to represent primary renal-type CCC arising in the
prostate. Microarray cluster analysis also supported the ﬁnal
pathological diagnosis.
The association of seminal vesicle cyst with ipsilateral renal
agenesis was ﬁrst reported in 1914, which became known as Zinner
syndrome.5 Abnormal development in the kidney and urinary tract
system during weeks 4 and 7 of gestation induces the condition of
this syndrome. Since the ejaculatory ducts are normally derived
from the mesonephric system, the ejaculatory ducts form abnor-
mally in this condition and ﬂuid builds up inside, forming a seminal
vesicle cyst.5 One possible hypothesis for development of CCC in the
prostate in the present case may include an embryologic renal
remnant in or adjacent to the prostate because of an embryogenesis
abnormality in the kidney and urinary tract system.
The microarray data using cluster analysis demonstrated that
the present case belonged to the cluster group of RCC. Therefore,
he was treated with TKI therapy in accordance with the protocol
Figure 2. Microscopic ﬁndings of biopsy (AeC) and resected sample (D and E). Histopathological examination revealed CK7-positive (A) and CK20- (B) and PSA-negative (C)
non-ciliated cuboidal cells, with cytoplasm ranging from clear to eosinophilic (D), suggestive of clear cell carcinoma. The coexistence of clear cell carcinoma (black arrowheads)
and normal prostate-like tissue (white arrowheads) without a deﬁned border between them is identiﬁed in only a very small region (E). (D and E): Hematoxylin-eosin
stain, 100.
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rapidly progressing cancer. Although the gene expression pattern
in the present case was similar to that of RCC, further studyFigure 3. Microarray cluster analysis demonstrates that the gene expression pattern of the s
cell carcinoma or prostate adenocarcinoma.should have been conducted to deﬁne in detail the biologic fea-
tures of renal-type CCC of the prostate and to establish a treat-
ment strategy.ample in this patient belonged to that of renal cell carcinoma, but not that of urothelial
Y. Sato et al. / Urology Case Reports 5 (2016) 9e1212Conclusion
Renal-type CCC of the prostate is extremely rare. The microarray
cluster analysis may be sometimes helpful in conﬁrming the diag-
nosis of an extremely rare disease.Conﬂict of interest
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